CONDITION

Malassezia Dermatitis

Why this matters now

Yeast dermatitis can develop at any age but commonly appears when conditions favour yeast proliferation—often secondary to allergies, hormonal changes, or other factors that alter the skin environment. Warm, humid weather and anatomical features like skin folds or floppy ears can create microenvironments where yeast thrives.

Initial presentations may involve localised redness, greasiness, or mild odour that can be easy to overlook. Without intervention, affected areas often spread, the characteristic smell intensifies, and skin changes such as thickening, darkening, and lichenification develop. Dogs frequently become intensely itchy, leading to self-trauma and secondary complications.

Signals & patterns

Early signals

Greasy or waxy skin texture

Affected areas may feel oily to the touch, with a sheen that differs from normal coat appearance.

Musty or yeasty odour

A characteristic smell often described as musty, bread-like, or corn chip-like may become noticeable, particularly in skin folds, ears, or between toes.

Redness in skin folds or between digits

Warm, moist areas like armpits, groin, lip folds, and interdigital spaces often show early signs of yeast overgrowth.

Mild itching with frequent licking

Dogs may pay increased attention to paws, ears, or other affected areas with repetitive licking or scratching.

Later signals

Thickened, darkened skin (lichenification)

Chronic inflammation leads to elephant skin-like changes with hyperpigmentation, particularly visible on the belly, underarms, or neck.

Intense itching and self-trauma

The itch can become severe enough to disrupt sleep and cause hair loss, excoriation, or bleeding from scratching.

Spreading to multiple body areas

What may begin in one location can extend to involve large portions of the body, often with concurrent ear involvement.

Secondary bacterial infection

Damaged, inflamed skin frequently develops bacterial overgrowth alongside the yeast, complicating the clinical picture.

Click to read about the biological mechanisms

How this is usually investigated

Diagnosis relies on identifying excessive yeast organisms in affected skin areas along with investigation into underlying conditions that may be driving the overgrowth.

Skin cytology

Purpose: Collecting and staining material from affected skin allows microscopic identification of yeast organisms and assessment of their numbers.
Considerations: A rapid, non-invasive test that can be performed during consultation. Finding numerous yeast organisms in affected areas supports the diagnosis.

Tape impression or acetate test

Purpose: Pressing clear tape or acetate strips against the skin collects surface organisms for microscopic examination.
Considerations: Particularly useful for greasy or scaly areas where swabbing may be less effective.

Ear cytology

Purpose: Since ear involvement commonly accompanies skin yeast, examining ear discharge can contribute diagnostic information.
Considerations: Concurrent ear and skin treatment may be needed if both areas are affected.

Allergy investigation

Purpose: As allergies commonly underlie yeast dermatitis, identifying allergic triggers may be important for long-term control.
Considerations: May involve dietary elimination trials, intradermal testing, or serology depending on suspected allergy type.

Hormonal evaluation

Purpose: Conditions affecting hormone balance can predispose to yeast overgrowth and may warrant investigation if indicated.
Considerations: Typically considered when clinical signs or history suggest possible endocrine involvement.

Options & trade-offs

Treatment aims to reduce yeast populations while addressing underlying conditions that allow overgrowth. Combination approaches often prove most effective.

Topical antifungal therapy

Medicated shampoos, mousses, or sprays containing antifungal agents can reduce yeast populations on the skin surface.

Trade-offs: Requires regular application and bathing commitment. Effective for mild cases or maintenance, but may not suffice alone for severe infections.

Systemic antifungal medication

Oral antifungal drugs treat yeast throughout the body and reach areas difficult to treat topically.

Trade-offs: More consistently effective for moderate to severe cases. Treatment duration varies, and monitoring may be recommended with some medications.

Management of underlying allergies

Controlling allergic inflammation reduces the skin environment changes that favour yeast proliferation.

Trade-offs: Essential for preventing recurrence but may require ongoing therapy. The specific approach depends on the allergy type identified.

Environmental and maintenance strategies

Regular bathing with appropriate products, keeping skin folds dry, and monitoring high-risk areas can help prevent recurrence.

Trade-offs: Time commitment for ongoing care. Most useful as part of a comprehensive management plan rather than sole intervention.

Common misconceptions

Misconception:

"Yeast infections indicate poor hygiene"

Reality:

Malassezia overgrowth typically reflects underlying conditions affecting skin health rather than cleanliness. The yeast is normally present; the issue is why it has proliferated.

Misconception:

"Once treated, the problem is permanently resolved"

Reality:

Without addressing underlying triggers such as allergies, many dogs experience recurrent episodes. Long-term management of predisposing factors often proves more important than treating individual flare-ups.

Misconception:

"Yeast dermatitis is contagious to people or other pets"

Reality:

The Malassezia species affecting dogs rarely cause problems in healthy humans or other animals. Standard hygiene is generally sufficient.

Dogs showing signs of greasy skin, characteristic odour, or intense itching in typical locations may benefit from cytological examination to assess yeast involvement. When yeast dermatitis is confirmed or suspected, investigating potential underlying conditions—particularly allergies—often helps guide both immediate treatment and longer-term management planning.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS